NASDAQ:HCAT
Health Catalyst, Inc.
Health Catalyst, Inc.'s revenue grew 1.5% in fiscal 2025 to $311.1M while operating margin fell to −51.7%. Free cash flow was −$237,000, −0.1% of revenue, and the diluted share count rose 16.1%.Summary generated from Health Catalyst, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$311.1M
Revenue growth+1.5%
Revenue, 5-yr CAGR+10.5%
Gross marginn/a
Operating margin−51.7%
Net margin−57.2%
ROIC−30.0%
Return on equity−58.3%
Debt / equity0.62
Free cash flow−$237,000
FCF margin−0.1%
Share count change+16.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 242 | 276 | 296 | 307 | 311 |
| Operating income | −144 | −140 | −127 | −70 | −161 |
| Net income | −153 | −137 | −118 | −70 | −178 |
| Free cash flow | −34 | −37 | −34 | 13 | −0 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Sep 16, 2026 - 8-KDirector or officer change
Sep 14, 2026 - 8-KDirector or officer change
Sep 8, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KTermination of a material agreement
Aug 6, 2026 - 8-KResults of a shareholder vote
Jul 20, 2026 - 8-KEntry into a material agreement
Jun 4, 2026